SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 323 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $611,000 | -5.6% | 18,463 | +0.0% | 0.01% | 0.0% |
| Q1 2019 | $647,000 | +17.4% | 18,459 | +11.3% | 0.01% | 0.0% |
| Q4 2018 | $551,000 | -36.7% | 16,591 | -4.0% | 0.01% | -26.7% |
| Q3 2018 | $870,000 | -16.3% | 17,288 | -0.5% | 0.02% | -25.0% |
| Q2 2018 | $1,040,000 | +38.1% | 17,369 | +5.6% | 0.02% | +25.0% |
| Q1 2018 | $753,000 | +22.0% | 16,448 | +6.3% | 0.02% | +23.1% |
| Q4 2017 | $617,000 | +1.1% | 15,471 | +1.4% | 0.01% | +8.3% |
| Q3 2017 | $610,000 | -3.0% | 15,259 | +4.5% | 0.01% | -14.3% |
| Q2 2017 | $629,000 | +52.7% | 14,596 | +10.7% | 0.01% | +40.0% |
| Q1 2017 | $412,000 | +37.8% | 13,182 | +11.3% | 0.01% | +42.9% |
| Q4 2016 | $299,000 | +76.9% | 11,846 | +72.9% | 0.01% | +75.0% |
| Q3 2016 | $169,000 | +19.9% | 6,853 | -1.3% | 0.00% | 0.0% |
| Q2 2016 | $141,000 | +34.3% | 6,944 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $105,000 | +69.4% | 6,944 | +50.0% | 0.00% | +50.0% |
| Q4 2015 | $62,000 | – | 4,629 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |